Gene arrays and temporal patterns of drug response: Corticosteroid effects on rat liver

被引:23
作者
Richard R. Almon
Debra C. DuBois
Keri E. Pearson
Dietrich A Stephan
William J. Jusko
机构
[1] Department of Biological Sciences, SUNY at Buffalo, Buffalo, NY 14260
[2] Department of Pharmaceutical Sciences, SUNY at Buffalo, Buffalo, NY 14260
[3] Research Center for Genetic Medicine, Children's National Medical Research Center, Washington
基金
美国国家卫生研究院;
关键词
Cluster analysis; Corticosteroids; Expression profiling; Glucocorticoids;
D O I
10.1007/s10142-003-0090-x
中图分类号
学科分类号
摘要
It was hypothesized that expression profiling using gene arrays can be used to distinguish temporal patterns of changes in gene expression in response to a drug in vivo, and that these patterns can be used to identify groups of genes regulated by common mechanisms. A corticosteroid, methylprednisolone (MPL), was administered intravenously to a group of 47 rats (Rattus rattus) that were sacrificed at 17 timepoints over 72 h after MPL administration. Plasma drug concentrations and hepatic glucocorticoid receptors were measured from each animal. In addition, RNAs prepared from individual livers were used to query Affymetrix genechips for mRNA expression patterns. Statistical analyses using Affymetrix and GeneSpring software were applied to the results. Cluster analysis revealed six major temporal patterns containing 196 corticosteroid-responsive probe sets representing 153 different genes. Four clusters showed increased expression with differences in lag-time, onset rate, and/or duration of transcriptional effect. A fifth cluster showed rapid reduction persisting for 18 h. The final cluster identified showed decreased expression followed by an extended period of increased expression. These results lend new insights into the diverse hepatic genes involved in the physiologic, therapeutic, and adverse effects of corticosteroids and suggest that a limited array of control processes account for the dynamics of their pharmacogenomic effects. © Springer-Verlag 2004.
引用
收藏
页码:171 / 179
页数:8
相关论文
共 26 条
[21]  
inhibitors of the synthesis and actions of adrenocortical hormones, Goodman & Gilman's The Pharmacological Basis of Therapeutics, pp. 1459-1486, (1996)
[22]  
Shalev A., Pise-Masison C., Radonovich M., Hoffmann S., Hirshberg B., Brady J., Harlan D., Oligonucleotide microarray analysis of intact human pancreatic islets: Identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway, Endocrinology, 143, pp. 3695-3698, (2002)
[23]  
Sun Y.-N., DuBois D.C., Almon R.R., Pyszczynski N.A., Jusko W.J., Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver, J. Pharmacokin Biopharm., 26, pp. 619-648, (1998)
[24]  
Sun Y.-N., DuBois D.C., Almon R.R., Jusko W.J., Fourth-generation model for corticosteroid pharmacodynamics: A model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver, J. Pharmacokin Biopharm., 26, pp. 289-317, (1998)
[25]  
Sun Y.-N., McKay L.I., DuBois D.C., Jusko W.J., Almon R.R., Pharmacokinetic/pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a receptor/gene-mediated mechanism, J. Pharmacol. Exp. Ther., 288, pp. 720-728, (1999)
[26]  
Takiguchi M., Mori M., Transcriptional regulation of genes for ornithine cycle enzymes, Biochem. J., 312, pp. 649-659, (1985)